These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6402686)

  • 1. [Long-term tolerance and therapeutic coronary effect of isosorbide-5-mononitrate. Open multicenter study of ISMO 20].
    Uberbacher HJ; Glocke M; Abshagen U
    MMW Munch Med Wochenschr; 1983 Jan; 125(4):76-8. PubMed ID: 6402686
    [No Abstract]   [Full Text] [Related]  

  • 2. [Randomized double-blind comparative study: glycerol trinitrate and isosorbide mononitrate].
    Kayali A
    Med Welt; 1983 Dec; 34(50):1441-4. PubMed ID: 6420639
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
    Smolarz A; Seeliger S; Glocke M
    Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mononitrates in long-term prophylaxis of angina pectoris: results of the first isosorbid-5-mononitrate symposium in Mannheim].
    Fortschr Med; 1981 Feb; 99(6):200-2. PubMed ID: 7024071
    [No Abstract]   [Full Text] [Related]  

  • 5. [Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
    Jansen W; Geppert R; Weidmann B; Tauchert M
    Med Klin (Munich); 1987 Nov; 82(24):854-9. PubMed ID: 3431518
    [No Abstract]   [Full Text] [Related]  

  • 6. Isosorbide-5-mononitrate and isosorbide dinitrate retard in the treatment of coronary heart disease: a multi-centre study.
    Bidoggia H
    Curr Med Res Opin; 1987; 10(9):601-11. PubMed ID: 3325229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-release isosorbide mononitrate for angina.
    Med Lett Drugs Ther; 1994 Feb; 36(915):13-4. PubMed ID: 8283957
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of isosorbide dinitrates and mononitrates in patients with ischemic heart disease and stable angina pectoris caused by stenosing coronary atherosclerosis].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Chotchaev KhKh; Naumov VG
    Klin Med (Mosk); 2000; 78(9):52-5. PubMed ID: 11051743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20).
    van Hasselt M; Weiss M; Haase W
    Curr Med Res Opin; 1984; 9(2):107-12. PubMed ID: 6443348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the therapeutic efficacy of slow-release isosorbide-5-mononitrate in ischemic cardiopathy].
    Schiavoni G; Bosimini E; Amico C
    Cardiologia; 1987 Nov; 32(11):1293-6. PubMed ID: 3447702
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemodynamic effect of 20 mg and 50 mg of 5-isosorbide mononitrate in acute and chronic therapy].
    Jansen W; Osterspey A; Fuchs M; Tauchert M; Schell U; Weste S; Hombach V
    Med Welt; 1982 Dec; 33(48):1756-62. PubMed ID: 6818416
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of a clinical multicenter study with Mono Mack 20 mg/40 mg].
    Schmidt G; Keller H; Jobst E
    Med Welt; 1983 Nov; 34(46):1322-4. PubMed ID: 6645932
    [No Abstract]   [Full Text] [Related]  

  • 13. Mononitrates as monotherapy in the prophylactic treatment of angina pectoris.
    Rehnqvist N; Nyberg G; Carlens P; Lindström E; Lundman T; Nordlander R; Ulvenstam G; Aberg A; Aström H
    Drugs; 1987; 33 Suppl 4():100-3. PubMed ID: 3622313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrate tolerance.
    Parker JO
    Herz; 1984 Jun; 9(3):137-45. PubMed ID: 6430767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

  • 16. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease.
    Uberbacher HJ; Steinorth G; Glocke M; Abshagen U
    Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of coronary disease with elantan. Results of a multicenter study].
    van Hasselt P; Weiss M; Haase W
    Fortschr Med; 1984 Jan; 102(1-2):55-60. PubMed ID: 6365709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Previous history and principles of the development of isosorbide-5-mononitrate (IS-5-MN)].
    Schaumann W
    Med Welt; 1981 Apr; 32(14A):479-80. PubMed ID: 7242305
    [No Abstract]   [Full Text] [Related]  

  • 19. Isosorbide mononitrate for angina.
    Med Lett Drugs Ther; 1992 Jun; 34(873):61. PubMed ID: 1608345
    [No Abstract]   [Full Text] [Related]  

  • 20. [Coronary therapeutic effectiveness of low-dose IS-5-MN in comparison with the combination IS-5-MH and metipranolol and placebo].
    Müller G; Uberbacher HJ; Glocke M
    Med Welt; 1983 Mar; 34(10):321-7. PubMed ID: 6133205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.